Recent evidence identifies SIRT7 as an emerging regulator of anti-cancer immunity, acting through intricate signaling networks that control not only tumor-intrinsic processes but also the reciprocal crosstalk between cancer cells and the tumor microenvironment, thereby shaping immune surveillance and anti-tumor responses. Here, SIRT7 is linked to cancer.